Revenio Group Oyj (HLSE: REG1V)
Health Care · Health Care Equipment & Supplies · FI
€14.82
+0.27% today · -39.4% 1Y
Revenio Group Oyj (HLSE: REG1V) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $458.89M and employs 246 people.
Over the last twelve months the share price has lost 39.4%, trading between 11.86 and 25.85.
Tweenvest scores Revenio Group Oyj across four factors: quality 81/100, value 84/100, growth 46/100, dividend 85/100. Its strongest factor is dividend.
REG1V price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $458.89M
- Revenue (TTM)
- $128.04M
- P/E
- 25.12
- EPS
- 0.59
- Dividend yield
- 2.96%
- Beta (5Y)
- 0.85
- 52-week high
- €25.85
- 52-week low
- €11.86
- Avg volume (3M)
- —
- Shares outstanding
- 26.61M
- Employees
- 246
- Next earnings
- —
About Revenio Group Oyj
Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company offers iCare IC100, ST500, and IC200 tonometers; iCare HOME2, a tonometer to measure eye pressure; iCare Probes that are accessories of iCare tonometer for measuring intraocular pressure (IOP); iCare TONOVET Pro, a tonometer designed for use in surgical or emergency settings; and iCare TONOVET Plus tonometer, which is used for measuring IOP on animal patients by general veterinary practitioners, veterinary ophthalmologists and other veterinary medical personnel. It also provides imaging devices comprising iCare EIDON, a device with confocal retinal imaging; iCare DRSplus, a device for pupil imaging; and iCare COMPASS, which provides fundus perimetry with true-color confocal retinal images. In addition, the company offers iCare ILLUME, a screening software that helps to detect the early signs of diabetic retinopathy, age-related macular degeneration, and glaucoma using artificial intelligence; iCare CLINIC cloud software to store long-term IOP data; and Oculo, an eye care software platform, which combines clinical communication, telehealth, remote patient monitoring and data analytics capabilities. Revenio Group Oyj was incorporated in 2001 and is based in Vantaa, Finland.
- ISIN
- FI0009010912
- Founded
- 2001
- Listed since
- Nov 20, 2008
- Exchange
- OMX Nordic Exchange Helsinki
- Currency
- EUR
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $200.95B | $116.13 | -0.46% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $131.36B | $371.84 | -0.46% |
| Stryker CorporationNYSE: SYK | $126.81B | $330.59 | +0.85% |
| Medtronic plcNYSE: MDT | $116.66B | $91.14 | -1.89% |
| EssilorLuxottica Société anonymeENXTPA: EL | $85.36B | €159.15 | -1.58% |
| Boston Scientific CorporationNYSE: BSX | $72.26B | $49.86 | +1.73% |
| HOYA CorporationTSE: 7741 | $52.49B | ¥24,995.00 | +0.40% |
| Edwards Lifesciences CorporationNYSE: EW | $52.38B | $90.87 | +0.41% |
Figures last refreshed Aug 18, 2026.